Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00111813
Status:
COMPLETED
Last Update Posted:
2015-05-21
First Post:
2005-05-25
Brief Title:
Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma MK-0683-015 EXT 1 AM1
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Myeloma |
Keywords: